These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 963439)

  • 1. Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers.
    Dennis NR; Evans K; Clayton B; Carter CO
    Br Med J; 1976 Sep; 2(6035):577-9. PubMed ID: 963439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.
    Perry TB; Fraser FC
    Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611
    [No Abstract]   [Full Text] [Related]  

  • 3. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study.
    Hutton EM; Thompson MW
    Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier detection and genetic counselling in Duchenne dystrophy.
    Dubowitz V
    Dev Med Child Neurol; 1975 Jun; 17(3):352-6. PubMed ID: 1107098
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Serum-creatine-kinase levels in carriers of Becker muscular dystrophy.
    Skinner R; Emery AE
    Lancet; 1974 Oct; 2(7887):1023-4. PubMed ID: 4138389
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection and genetic counselling of subclinical and carrier states in Duchenne muscular dystrophy.
    Das PK; Sen SK
    Eur Neurol; 1979; 18(2):91-5. PubMed ID: 456392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of carriers of benign X-linked muscular dystrophy.
    Emery AE; Clack ER; Simon S; Taylor JL
    Br Med J; 1967 Dec; 4(5578):522-3. PubMed ID: 6065987
    [No Abstract]   [Full Text] [Related]  

  • 10. The detection of female carriers of pseudohypertrophic muscular dystrophy.
    Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL
    Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982
    [No Abstract]   [Full Text] [Related]  

  • 11. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 12. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy.
    Skinner R; Emery AE; Anderson AJ; Foxall C
    J Med Genet; 1975 Jun; 12(2):131-4. PubMed ID: 1142377
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy and serum C.P.K. levels in potential carriers of severe X-linked muscular dystrophy.
    Blyth H; Hughes BP
    Lancet; 1971 Apr; 1(7704):855-6. PubMed ID: 4102542
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. I. Analysis of results from 29 studies.
    Gale AN; Murphy EA
    J Chronic Dis; 1978 Feb; 31(2):101-9. PubMed ID: 659567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Present-day clinico-genetic framework of Duchenne's muscular dystrophy].
    Meola G
    Riv Neurol; 1989; 59(1):8-14. PubMed ID: 2669113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of carriers and genetic counseling in duchenne muscular dystrophy by ribosomal protein synthesis.
    Ionasescu V; Zellweger H; Burmeister L
    Acta Neurol Scand; 1976 Nov; 54(5):442-52. PubMed ID: 998168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pyruvate kinase in carriers of Duochenne muscular dystrophy.
    Yamuna S; Valmikinathan K; Burt D; Emery AE
    Clin Chim Acta; 1977 Aug; 79(1):277-9. PubMed ID: 890959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counselling in neuromuscular diseases in Western Australia.
    Hurse PV; Kakulas BA
    Proc Aust Assoc Neurol; 1974; 11():145-53. PubMed ID: 4469625
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.